Canadian application, no grantCanada
1,4,5,6-tetrahydroimidazo4,5-ddiazepine derivative or salt thereof
CA 2425892 A1 · Owner: Yamanouchi Pharmaceutical Co. Ltd. · Inventors: Koshio, Hiroyuki; Wakayama, Ryutaro; Sato, Ippei
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds having an excellent arginine vasopressin antagonism are provided. Namely, novel 1,4,5,6-tetrahydroimidazo4,5-dbenzazepine derivatives or pharmaceutically acceptable salts thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 27, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 27, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 27, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 27, 2001
GrantedNo grant recorded
Term endedNovember 27, 2021
Patent numberCA 2425892 A1
Classification (IPC)C07D487/04 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.